| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Achieving treatment optimization with sildenafil citrate (Viagra®) in patients with erectile dysfunction 1 1 This supplement was funded by Pfizer Inc. Andrew R. McCullough, James H. Barada, Ahmed Fawzy, Andre T. Guay, and Dimitrios Hatzichristou are paid consultants to, and study investigators funded by, Pfizer Inc.
|
McCullough, Andrew R
|
|
2002
|
60 |
2S2 |
p. 28-38
11 p.
|
artikel
|
| 2 |
A 4-year update on the safety of sildenafil citrate (Viagra®) 1 1 This supplement is sponsored by Pfizer Inc. Harin Padma-Nathan, Ian Eardley, Robert A. Kloner, and Francesco Montorsi are paid consultants to, and study investigators funded by, Pfizer Inc. Alan M. Laties is a paid consultant to Pfizer Inc.
|
Padma-nathan, Harin
|
|
2002
|
60 |
2S2 |
p. 67-90
24 p.
|
artikel
|
| 3 |
Depression, antidepressant therapies, and erectile dysfunction: clinical trials of sildenafil citrate (Viagra®) in treated and untreated patients with depression
|
Nurnberg, H.George
|
|
2002
|
60 |
2S2 |
p. 58-66
9 p.
|
artikel
|
| 4 |
Efficacy and safety of sildenafil citrate (Viagra®) in black and Hispanic American men
|
Young, Jay M
|
|
2002
|
60 |
2S2 |
p. 39-48
10 p.
|
artikel
|
| 5 |
Efficacy and safety of sildenafil citrate (Viagra®) in men with erectile dysfunction and spinal cord injury: a review
|
Derry, Fadel
|
|
2002
|
60 |
2S2 |
p. 49-57
9 p.
|
artikel
|
| 6 |
Introduction
|
Padma-Nathan, Harin
|
|
2002
|
60 |
2S2 |
p. 1-3
3 p.
|
artikel
|
| 7 |
Phosphodiesterase type 5 as a pharmacologic target in erectile dysfunction
|
Corbin, Jackie D
|
|
2002
|
60 |
2S2 |
p. 4-11
8 p.
|
artikel
|
| 8 |
The efficacy of sildenafil citrate (Viagra®) in clinical populations: an update 1 1 This supplement was funded by Pfizer Inc. Culley C. Carson is a paid consultant to, and a study investigator partially funded by Pfizer, Inc.
|
Carson, Culley C
|
|
2002
|
60 |
2S2 |
p. 12-27
16 p.
|
artikel
|
Tijdschrift beschrijving